NEW YORK, Oct. 7 (GenomeWeb News) - Isis Pharmaceuticals said today it has received a three-year grant of up to $6 million from the US Centers for Disease Control and Prevention to develop an RNA-based diagnostic technology for human and animal infectious diseases as well as biodefense.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

University of California, San Diego, researchers have developed a gene drive to control a fruit-destroying fly.

A new study of a β-thalassemia gene therapy appears promising, according to NPR.

In Nature this week: hair color genes, hybridization between 13-year and 17-year cicadas, and more.

Futurism writes that gene doping could be the next generation of cheating in sports.